P2X Receptor

P2X receptor antagonists and modulators act on ion channels gated by extracellular adenosine triphosphate (ATP). Cloning of the P2X1 and P2X2 subunits in 1994 defined a new structural class of ligand-gated ion channels. Seven subunits, P2X1 to P2X7, assemble as trimers that pass sodium, potassium and calcium ions. P2X3 and P2X2/3 receptors on sensory neurons are studied in pain signaling, and P2X7 receptors in inflammation. In 1996 the cytolytic P2Z receptor of macrophages was identified as P2X7, which opens large pores during sustained ATP exposure. A-317491 sodium salt hydrate and AF-353 block P2X3 and P2X2/3 receptors. A 740003 and A 438079 hydrochloride are P2X7 antagonists, whereas NF 279 acts at P2X1.

Items 51-75 of 94

  • NF110
    Cat. No.
    A67901

    NF110

    NF110 is a P2X3 receptor antagonist with a Ki of 36 nM, demonstrating selectivity as it is inactive toward stably expressed P2Y receptors (IC50s > 10 µM). It effectively inhibits alpha, beta-methylene-ATP-induced currents in rat dorsal root ganglia neurons, with an IC50 value of 527 nM. This compound is valuable for researching pain pathways and receptor signaling in nociceptive responses.

    5 mg
    $330.00
    10 mg
    $495.00
    All 2 sizes
  • 2-Methylthio-ATP tetrasodium
    Cat. No.
    A67902

    2-Methylthio-ATP tetrasodium

    2-Methylthio-ATP tetrasodium is a non-specific P2-receptor agonist that modulates purinergic signaling pathways. It has been shown to cause noncompetitive inhibition of ADP-induced aggregation in human platelets. This reagent is valuable for studies investigating platelet function, receptor signaling, and related cardiovascular research applications.

    1 mg
    $175.00
    2.8 mg
    $205.00
    All 2 sizes
  • (E/Z)-Sivopixant
    Cat. No.
    A67904

    (E/Z)-Sivopixant

    Synonyms: (E/Z)-S-600918

    (E/Z)-Sivopixant is a selective antagonist of the P2X3 receptor, exhibiting an IC50 value of 4 nM. This compound demonstrates significant biological activity in modulating pain signals and neurogenic inflammation. It is primarily employed in research related to respiratory diseases, providing insights into potential therapeutic strategies for conditions associated with P2X3 receptor activation.

    1 mg
    $70.00
    5 mg
    $185.00
    All 7 sizes
  • P2X3-IN-1
    Cat. No.
    A67905

    P2X3-IN-1

    P2X3-IN-1 is a selective inhibitor of the P2X3 receptor, which plays a crucial role in mediating pain and other neurogenic responses. This compound demonstrates significant biological activity in modulating P2X3 receptor signaling, making it valuable for research into neurogenic diseases and pain pathways. Researchers can utilize P2X3-IN-1 to explore therapeutic strategies for conditions associated with P2X3 receptor dysfunction.

    5 mg
    $1,125.00
    50 mg
    $2,280.00
    All 3 sizes
  • RO-3
    Cat. No.
    A67906

    RO-3

    RO-3 is a potent orally active antagonist of the P2X3 and P2X2/3 receptors, exhibiting pIC50 values of 5.9 and 7.0 for human homomultimeric P2X3 and heteromultimeric P2X2/3 receptors, respectively. This compound demonstrates selectivity for P2X3 and P2X2/3, with IC50 values exceeding 10 μM against all other functional P2X receptor homomultimers, including P2X1, P2X2, P2X4, P2X5, and P2X7. RO-3 is valuable for research focused on pain pathways and chronic pain conditions due to its specific receptor interactions.

    1 mg
    $25.00
    5 mg
    $50.00
    All 6 sizes
  • BzATP triethylammonium
    Cat. No.
    A67907

    BzATP triethylammonium

    Synonyms: Benzoylbenzoyl-ATP triethylammonium

    BzATP triethylammonium is a potent P2X receptor agonist that exhibits varying pEC50 values across multiple P2X receptor subtypes, including 8.74 for P2X1, 5.26 for P2X2, 7.10 for P2X3, 7.50 for P2X2/3, 6.19 for P2X4, and 6.31 for P2X7. It demonstrates significant activity at P2X7 receptors, with EC50 values of 3.6 μM for rat P2X7 and 285 μM for mouse P2X7. BzATP triethylammonium is valuable for research investigating purinergic signaling pathways and receptor pharmacology.

    1 mg
    $35.00
    5 mg
    $80.00
    All 5 sizes
  • P2X4 antagonist-1
    Cat. No.
    A67908

    P2X4 antagonist-1

    P2X4 antagonist-1 is a potent inhibitor of the P2X4 receptor, exhibiting an IC50 of 15 nM. This compound effectively modulates P2X4 signaling, making it valuable for research involving pain modulation, neuroinflammation, and cardiovascular regulation. Its specificity towards P2X4 supports studies aimed at understanding its role in various pathophysiological conditions.

    1 mg
    $40.00
    5 mg
    $95.00
    All 7 sizes
  • Ro 0437626
    Cat. No.
    A67909

    Ro 0437626

    Ro 0437626 is a selective antagonist of the purinergic P2X1 receptor, exhibiting an IC50 value of 3 μM. It demonstrates low affinity for P2X2, P2X3, and P2X2/3 receptors, with IC50 values exceeding 100 μM. This compound is valuable for research applications involving the modulation of P2X1 receptor signaling pathways, contributing to studies in cardiovascular and pain research.

    Out of stock

    All 3 sizes
  • AZ 11645373
    Cat. No.
    A67910

    AZ 11645373

    AZ 11645373 is a selective antagonist of the human P2X7 receptor, demonstrating significant potency without affecting the rat variant. It effectively inhibits ATP-induced release of IL-1β from lipopolysaccharide-activated THP-1 cells, with an IC50 value of 90 nM. This compound is valuable for studies focused on inflammatory processes and purinergic signaling pathways.

    1 mg
    $40.00
    5 mg
    $90.00
    All 7 sizes
  • MRS4719
    Cat. No.
    A67911

    MRS4719

    MRS4719 is a potent antagonist of the P2X4 receptor, exhibiting an IC50 value of 0.503 μM in human P2X4 receptor assays. This compound demonstrates neuroprotective effects by reducing infarct volume and promoting neurorehabilitation in models of ischemic stroke. Additionally, MRS4719 effectively decreases ATP-induced intracellular calcium influx in primary human monocyte-derived macrophages, making it a valuable reagent for studying ischemic stroke and related neuroinflammatory processes.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • AF-353 hydrochloride
    Cat. No.
    A67912

    AF-353 hydrochloride

    Synonyms: Ro-4 hydrochloride

    AF-353 hydrochloride is a potent and selective antagonist of the P2X3 and P2X2/3 receptors, exhibiting a pIC50 of 8.0 for both human and rat P2X3 and a pIC50 of 7.3 for human P2X2/3. This compound is notable for its oral bioavailability, making it suitable for in vivo studies. AF-353 hydrochloride is primarily utilized in research applications focused on pain modulation and the study of purinergic signaling pathways.

    1 mg
    $65.00
    5 mg
    $210.00
    All 3 sizes
  • P2X3 antagonist 38
    Cat. No.
    A67913

    P2X3 antagonist 38

    P2X3 antagonist 38 is a potent oral antagonist of the P2X3 receptor, demonstrating IC50 values of 0.132 µM for human P2X3, 0.165 µM for rat P2X3, and 0.421 µM for guinea pig P2X3. This compound is valuable in studies focused on pain modulation and respiratory disorders, positioning it as a significant tool for researching the role of P2X3 in various biological processes. Its high selectivity and efficacy make it suitable for in vivo applications in pharmacological investigations.

    25 mg
    $1,405.00
    50 mg
    $1,790.00
    All 3 sizes
  • Purotoxin 1
    Cat. No.
    A67914

    Purotoxin 1

    Purotoxin 1 is a selective P2X3 receptor inhibitor. It exhibits significant antinociceptive effects in animal models of inflammatory pain, making it a valuable tool for pain research. Isolated from the venom of the wolf spider Geolycosa sp., Purotoxin 1 can be utilized in studies aimed at understanding pain mechanisms and developing new analgesic therapies.

    1 mg
    $860.00
    All 1 sizes
  • (S)-JNJ-54166060
    Cat. No.
    A67915

    (S)-JNJ-54166060

    (S)-JNJ-54166060 is a selective P2X7 antagonist, exhibiting potent inhibitory activity against the P2X7 receptor. This compound is useful in research related to chronic inflammatory diseases, neurodegeneration, and pain pathways, as well as studying the role of P2X7 in immune responses. Its specificity and efficacy make it a valuable tool for investigating the therapeutic potential of modulating P2X7 signaling.

    Out of stock

    All 3 sizes
  • NF864
    Cat. No.
    A67916

    NF864

    NF864 is a selective inhibitor of the P2X1 receptor, primarily expressed in human platelets. This compound effectively disrupts ATP-mediated signaling cascades involved in platelet activation and aggregation. NF864 is useful in research applications focused on cardiovascular disease, thrombosis, and platelet-related disorders, allowing scientists to investigate the role of P2X1 in vascular biology.

    25 mg
    $1,275.00
    All 1 sizes
  • MRS4596
    Cat. No.
    A67917

    MRS4596

    MRS4596 is a potent and selective antagonist of the P2X4 receptor, exhibiting an IC50 value of 1.38 μM for the human P2X4 receptor. This compound demonstrates neuroprotective and neuro-rehabilitative effects in models of ischemic stroke. MRS4596 is applicable in the study of ischemic stroke and associated therapeutic strategies.

    Out of stock

    All 3 sizes
  • Iso-PPADS tetrasodium
    Cat. No.
    A67919

    Iso-PPADS tetrasodium

    Iso-PPADS tetrasodium is a selective antagonist of the P2X purinoceptors, specifically targeting P2X1 and P2X3 receptors with IC50 values of 43 nM and 84 nM, respectively. This compound is known for its neuroprotective effects, particularly in the context of ventilator-induced brain injury (VIBI). Iso-PPADS tetrasodium is useful for researchers investigating purinergic signaling pathways and their implications in various neurological conditions.

    5 mg
    $150.00
    10 mg
    $245.00
    All 2 sizes
  • JNJ-54166060
    Cat. No.
    A67920

    JNJ-54166060

    JNJ-54166060 is a potent and selective antagonist of the P2X7 receptor, exhibiting IC50 values of 4 nM for the human, 115 nM for the rat, and 72 nM for the mouse P2X7 receptor. This compound modulates the purinergic signaling pathway, influencing processes such as inflammation and cell death. JNJ-54166060 is valuable for research applications related to autoimmune diseases, neuroinflammation, and other conditions where P2X7 receptor modulation is of interest.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • P2X4 antagonist-2
    Cat. No.
    A67921

    P2X4 antagonist-2

    P2X4 antagonist-2 is a selective antagonist of the P2X4 purinergic receptor, exhibiting an IC50 of 24 nM. This compound effectively inhibits ATP-induced P2X4 receptor activation, providing valuable insights into the role of P2X4 in various physiological and pathological processes. It is suitable for research focused on inflammation, pain signaling, and neurobiology.

    Out of stock

    All 3 sizes
  • Relicpixant
    Cat. No.
    A67922

    Relicpixant

    Relicpixant is a potent antagonist of the purinergic P2X receptor family. It has been shown to effectively inhibit P2X receptor-mediated signaling pathways, making it valuable for studying the role of purinergic signaling in various physiological and pathological processes. This compound is applicable in research areas such as neurobiology, pain modulation, and inflammation, where P2X receptors play critical roles.

    25 mg
    $1,530.00
    50 mg
    $1,950.00
    All 3 sizes
  • P2X4-IN-1
    Cat. No.
    A67923

    P2X4-IN-1

    P2X4-IN-1 is a potent inhibitor of the P2X4 receptor, which is involved in various physiological processes including pain perception and inflammation. This compound demonstrates significant biological activity by selectively blocking P2X4 receptor signaling. Its application in research allows for the investigation of therapeutic strategies for diseases associated with P2X4 receptor dysregulation.

    Out of stock

    All 3 sizes
  • P2X3 antagonist 37
    Cat. No.
    A67924

    P2X3 antagonist 37

    P2X3 antagonist 37 is a selective antagonist of the P2X3 receptor, exhibiting an inhibitory concentration (IC50) of 32.45 nM for human P2X3. This compound interrupts ATP-mediated signaling, making it a valuable tool for research into pain pathways and bladder dysfunction. It supports investigations exploring P2X3 receptor roles in neurobiology and related therapeutic applications.

    Out of stock

    All 3 sizes
  • Ro-51
    Cat. No.
    A67925

    Ro-51

    Ro-51 is a selective antagonist of the P2X3 and P2X2/3 receptors, demonstrating IC50 values of 2 nM and 5 nM, respectively. This compound effectively inhibits ATP-mediated signaling through these receptors, making it a valuable tool in pain research. Its specificity and potency allow for detailed investigations into the role of purinergic signaling in nociception and associated pain pathways.

    5 mg
    $350.00
    10 mg
    $575.00
    All 3 sizes
  • P2X3 antagonist 36
    Cat. No.
    A67926

    P2X3 antagonist 36

    P2X3 antagonist 36 is a potent antagonist of the P2X3 receptor, which plays a critical role in the modulation of pain and sensory signaling. This compound effectively inhibits P2X3 activity, making it a valuable tool for exploring the mechanisms underlying pain pathways. It is particularly useful in research focused on pain management and the development of analgesic therapies.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • 8-Bromo-ATP
    Cat. No.
    A67927

    8-Bromo-ATP

    Synonyms: 8-Bromoadenosine 5'-triphosphate; 8-Br-ATP

    8-Bromo-ATP, an ATP analogue, serves as a potent agonist for purinergic P2X receptors. This compound demonstrates cytotoxic effects on multiple myeloma cells, with an IC50 value of 23.1 μM, highlighting its potential for cancer research. 8-Bromo-ATP is useful in studies investigating purinergic signaling and its implications in tumor biology.

    5 mg
    $795.00
    All 1 sizes

Items 51-75 of 94

Added to your cart

View Cart Checkout

    Loading...